Circulating osteogenic cells: Characterization and relationship to rates of bone loss in postmenopausal women

Bone

Volumn 47, Issue 1, 2010, Pages 83-92

  Undale, Anita ^a   Srinivasan, Bhuma ^a   Drake, Matthew ^a   McCready, Louise ^a   Atkinson, Elizabeth ^a   Peterson, James ^a   Riggs, B Lawrence ^a   Amin, Shreyasee ^a   Moedder, U I ^a   Khosla, Sundeep ^a  

^a MAYO CLINIC   (United States)

Author keywords

Bone loss; Menopause; Osteoblast; Osteoporosis; Progenitors

Indexed keywords

15 HYDROXYPROSTAGLANDIN DEHYDROGENASE; CD45 ANTIGEN; COLLAGEN TYPE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERFERON REGULATORY FACTOR 3; MESSENGER RNA; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEONECTIN; OSTEOPONTIN; OSTEOPROTEGERIN; PARATHYROID HORMONE RECEPTOR 1; SMAD3 PROTEIN; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA2;

ADULT; AGED; ARTICLE; BONE MINERALIZATION; CELL LINEAGE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; OSTEOBLAST; OSTEOLYSIS; PERIPHERAL BLOOD STEM CELL; POSTMENOPAUSE OSTEOPOROSIS;

AGED; ALKALINE PHOSPHATASE; ANTIBODIES; BIOTINYLATION; BLOOD CELLS; BLOOD PROTEINS; BONE MARROW CELLS; BONE RESORPTION; CALCIFICATION, PHYSIOLOGIC; CELL LINEAGE; CELL MOVEMENT; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; MIDDLE AGED; POLYMERASE CHAIN REACTION; POSTMENOPAUSE; RNA, MESSENGER; STATISTICS, NONPARAMETRIC;

EID: 77954760820     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2010.03.018     Document Type: Article

References (41)

1. Chamberlain G., Fox J., Ashton B., Middleton J. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 2007, 25:2739-2749.
2. Gronthos S., Fitter S., Diamond P., Simmons P.J., Itescu S., Zannettino A.C.W. A novel monoclonal antibody (STRO-3) identifies an isoform of tissue nonspecific alkaline phosphatase expressed by multipotent bone marrow stromal stem cells. Stem Cells Dev 2007, 16:953-963.
3. Long M.W., Williams J.L., Mann K.G. Expression of human bone-related proteins in the hematopoietic microenvironment. J Clin Invest 1990, 86:1387-1395.
4. Long M.W., Robinson J.A., Ashcraft E.A., Mann K.G. Regulation of human bone marrow-derived osteoprogenitor cells by osteogenic growth factors. J Clin Invest 1995, 95:881-887.
5. Long M.W., Ashcraft E.K., Normalle D., Mann K.G. Age-related phenotypic alterations in populations of purified human bone precursor cells. J Gerontol 1999, 54A:B54-B62.
6. Eipers P.G., Kale S., Taichman R.S., Pipia G.G., Swords N.A., Mann K.G., et al. Bone marrow accessory cells regulate human bone precursor cell development. Exp Hematol 2000, 28:815-825.
7. Eghbali-Fatourechi G.Z., Lamsam J., Fraser D., Nagel D.A., Riggs B.L., Khosla S. Circulating osteoblast-lineage cells in humans. N Engl J Med 2005, 352:1959-1966.
8. Eghbali-Fatourechi G.Z., Moedder U.I., Charatcharoenwitthaya N., Sanyal A., Undale A.H., Clowes J.A., et al. Characterization of circulating osteoblast linage cells in humans. Bone 2007, 40:1370-1377.
9. Otsuru S., Tamai K., Yamazaki T., Yoshikawa H., Kaneda Y. Bone marrow-derived osteoblast progenitor cells in circulating blood contribute to ectopic bone formation in mice. Biochem Biophys Res Commun 2007, 354:453-458.
10. Otsuru S., Tamai K., Yamazaki T., Yoshikawa H., Kaneda Y. Circulating bone marrow-derived osteoblast progenitor cells are recruited to the bone-forming site by CXCR4/stromal cell-derived factor-1 pathway. Stem Cells 2008, 26:223-234.
11. Suda R.K., Billings P.C., Egan K.P., Kim J.H., McCarrick-Walmsley R., Glaser D.L., et al. Circulating osteogenic precursor cells in heterotopic bone formation. Stem Cells 2009, 27:2209-2219.
12. Kalajzic Z., Li H., Wang L.-P., Jiang X., Lamothe K., Adams D.J., et al. Use of an alpha-smooth muscle actin GFP reporter to identify an osteoprogenitor population. Bone 2008, 43:501-510.
13. Sacchetti B., Funari A., Michienzi S., Di Cesare S., Piersanti S., Saggio I., et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 2007, 131:324-336.
14. Riggs B.L., Melton L.J.I., Robb R.A., Camp J.J., Atkinson E.J., McDaniel L., et al. A population-based assessment of rates of bone loss at multiple skeletal sites: evidence for substantial trabecular bone loss in young adult women and men. J Bone Miner Res 2008, 23:205-214.
15. Riggs B.L., Melton L.J., Robb R.A., Camp J.J., Atkinson E.J., Peterson J.M., et al. Population-based study of age and sex differences in bone volumetric density, size, geometry, and structure at different skeletal sites. J Bone Miner Res 2004, 19:1945-1954.
16. Lawson G.M., Katzmann J.A., Kimlinger T.K., O'Brien J.F. Isolation and preliminary characterization of a monoclonal antibody which interacts preferentially with the liver isoenzymes of human alkaline phosphatase. Clin Chem 1985, 31:381-385.
17. Dafforn A., Chen P., Deng G., Herrler M., Iglehart D., Koritala S., et al. Linear mRNA amplification from as little as 5ng total RNA for global gene expression. Biotechniques 2004, 37:854-857.
18. Nygaard V., Hovig E. Options available for profiling small samples: a review of sample amplification technology when combined with microarray profiling. Nucleic Acids Res 2006, 34:996-1014.
19. Radonic A., Thulke S., Mackay I.M., Landt O., Siegert W., Nitsche A. Guideline to reference gene selection for quantitative real-time PCR. Biochem Biophys Res Commun 2004, 313:856-862.
20. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002, 3:1-0-34.11. [research0034].
21. Zhao S., Fernald R.D. Comprehensive algorithm for quantitative real-time polymerase chain reaction. J Comput Biol 2005, 12:1047-1064.
22. Khosla S., Amin S., Singh R.J., Atkinson E.J., Melton L.J., Riggs B.L. Comparison of sex steroid measurements in men by immunoassay versus mass spectroscopy and relationships with cortical and trabecular volumetric bone mineral density. Osteoporos Int 2008, 19:1465-1471.
23. Tanaka Y., Maruo A., Fujii K., Nomi M., Nakamura T., Eto S., et al. Intercellular adhesion molecule 1 discriminates functionally different populations of human osteoblasts: characteristic involvement of cell cycle regulators. J Bone Miner Res 2000, 15:1912-1923.
24. Everts V., Delaisse J.M., Korper W., Jansen D.C., Tigchelaar-Gutter W., Saftig P., et al. The bone lining cell: its role in cleaning howship's lacunae and initiating bone formation. J Bone Miner Res 2002, 17:77-90.
25. Kuznetsov S.A., Mankani M.H., Leet A.I., Ziran N., Gronthos S., Robey P.G. Circulating connective tissue precursors: extreme rarity in humans and chondrogenic potential in guinea pigs. Stem Cells 2007, 25:1830-1839.
26. Kearns A.E., Khosla S., Kostenuik P.J. Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease. Endocr Rev 2008, 29:155-192.
27. Xie Y., Yin T., Wiegraebe W., He X.C., Miller D., Stark D., et al. Detection of functional haematopoietic stem cell niche using real-time imaging. Nature 2009, 457:97-101.
28. Uppal S., Diggle C.P., Carr I.M., Fishwick C.W., Ahmed M., Ibrahim G.H., et al. Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy. Nat Genet 2008, 40:789-793.
29. Hikiji H., Takato T., Shimizu T., Ishii S. The roles of prostanoids, leukotrienes, and platelet-activating factor in bone metabolism and disease. Prog Lipid Res 2008, 47:107-126.
30. Yuksel-Konuk B., Sirmaci A., Ayten G.E., Ozdemir M., Asian I., Yilmaz-Turay U., Erdogan Y., Tekin M. Homozygous mutations in the 15-hydroxyprostaglandin dehydrogenase gene in patients with primary hypertrophic osteoarthropathy. Rheumatol Int 2009, 30:39-43.
31. Yoneyama M., Suhara W., Fujita T. Control of IRF-3 activation by phosphorylation. J Interferon Cytokine Res 2002, 22:73-76.
32. Gao Y., Grassi F., Ryan M.R., Terauchi M., Page K., Yang X., et al. IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation. J Clin Invest 2007, 117:122-132.
33. Duque G., Huang D.C., Macoritto M., Rivas D., Yang X.F., Ste-Marie L.G., et al. Autocrine regulation of interferon gamma in mesenchymal stem cells plays a role in early osteoblastogenesis. Stem Cells 2009, 27:550-558.
34. Fox S.W., Lovibond A.C. Current insights into the role of transforming growth factor-beta in bone resorption. Mol Cell Endocrinol 2005, 243:19-26.
35. Weitzmann M.N., Pacifici R. Estrogen deficiency and bone loss: an inflammatory tale. J Clin Invest 2006, 116:1186-1194.
36. Derynck R., Zhang Y.E. Smad-dependent and Smad-independent pathways in TGF-beta family signaling. Nature 2003, 425:577-584.
37. Grimsby S., Jaensson H., Dubrovska A., Lomnytska M., Hellman U., Souchelnytskyi S. Proteomics-based identification of proteins interacting with Smad3: SREBP-2 forms a complex with Smad3 and inhibits its transcriptional activity. FEBS Lett 2004, 577:93-100.
38. Xu L., Corcoran R.B., Welsh J.W., Pennica D., Levine A.J. WISP-1 is a Wnt-1- and beta-catenin-responsive oncogene. Genes Dev 2000, 14:585-595.
39. French D.M., Kaul R.J., D'Souza A.L., Crowley C.W., Bao M., Frantz G.D., Filvaroff E.H., Desnoyers L. WISP-1 is an osteoblastic regulator expressed during skeletal development and fracture repair. Am J Pathol 2004, 165:855-867.
40. Rogers A., Eastell R. Review: Circulating osteoprotegerin and receptor activator for nuclear factor kappaB ligand: clinical utility in metabolic bone disease assessment. J Clin Endocrinol Metab 2005, 90:6323-6331.
41. Pirro M., Leli C., Fabbriciani G., Manfredelli M.R., Callarelli L., Bagaglia F., et al. Association between circulating osteoprogenitor cell numbers and bone mineral density in postmenopausal osteoporosis. Osteoporos Int 2010, 21:297-306.